DCF — MEDSTAR SOUTHERN MARYLAND HOSPITAL C
Enterprise Value: $-569.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-569.2M
Enterprise Value
$-177.4M
PV of Cash Flows
$-391.7M
PV of Terminal Value
$-630.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $278.1M | $-36.9M | -13.0% | $-48.7M | $-44.2M |
| Year 2 | $286.4M | $-35.1M | -12.0% | $-47.3M | $-39.1M |
| Year 3 | $295.0M | $-33.2M | -11.0% | $-45.7M | $-34.4M |
| Year 4 | $303.9M | $-32.7M | -11.0% | $-45.6M | $-31.1M |
| Year 5 | $313.0M | $-32.9M | -11.0% | $-46.2M | $-28.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-569.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$270.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13766566861584825
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5